Multiple myeloma

February 10, 2023

Trial Spotlight: A Closer Look at ECOG-ACRIN’s Myeloma Studies

These three trials are open and enrolling adults with multiple myeloma or at high risk of developing the disease
August 17, 2021

Now Enrolling: EAA171/OPTIMUM for Myeloma

This randomized phase III trial aims to determine if the addition of ixazomib to lenalidomide improves overall survival in patients with multiple myeloma
February 25, 2021

Trial Spotlight: Shaji Kumar on the EQUATE Study for Newly Diagnosed Multiple Myeloma

The randomized EAA181 phase III trial seeks to determine whether there is any survival benefit from adding a fourth drug to induction therapy—and if so, in which patients